These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2701579)

  • 1. The role of mucosal immunity in development of an acquired immunodeficiency syndrome (AIDS) vaccine: workshop summary.
    Muul LM; Glass MJ; Wescott SL; Burkhardt AL; Koff WC; Strober WG
    Reg Immunol; 1989; 2(3):188-92. PubMed ID: 2701579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of an AIDS vaccine: progress and promise.
    Fauci AS; Fischinger PJ
    Public Health Rep; 1988; 103(3):230-6. PubMed ID: 3131812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [AIDS vaccines: an enigma in vaccine development].
    Dorner F; Barrett N
    Wien Klin Wochenschr; 1990 Jan; 102(2):51-8. PubMed ID: 1689919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of the development of an AIDS vaccine.
    Lasky LA
    Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
    Schneider T; Ullrich R; Zeitz M
    Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AIDS: possibilities of active immunization].
    Heinz F
    Wien Med Wochenschr; 1988 Oct; 138(19-20):535-7. PubMed ID: 3059693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS vaccine.
    Minn Med; 1991 Jan; 74(1):41. PubMed ID: 2002792
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
    Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
    Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS vaccine.
    Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.
    Belyakov IM; Hel Z; Kelsall B; Kuznetsov VA; Ahlers JD; Nacsa J; Watkins DI; Allen TM; Sette A; Altman J; Woodward R; Markham PD; Clements JD; Franchini G; Strober W; Berzofsky JA
    Nat Med; 2001 Dec; 7(12):1320-6. PubMed ID: 11726972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenets of protection from progression to AIDS: lessons from the immune responses to HIV-2 infection.
    Leligdowicz A; Rowland-Jones S
    Expert Rev Vaccines; 2008 Apr; 7(3):319-31. PubMed ID: 18393602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is AIDS vaccine research at a turning point?
    Levy JP
    J Hum Virol; 2000; 3(2):83-7. PubMed ID: 10850894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization against HIV. Problems in developing a vaccine].
    Uhl D
    Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D; Ogra PL
    Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental factors in HIV/AIDS epidemic development: new perspectives for gender equity and global protection against HIV transmission.
    Alfsen A
    Ann N Y Acad Sci; 2004 Jun; 1023():164-74. PubMed ID: 15253905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS vaccines: concepts and first trials.
    Sonigo P; Montagnier L; Tiollais P; Girard M
    Immunodefic Rev; 1989; 1(4):349-66. PubMed ID: 2698645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological considerations in the development of a human immunodeficiency virus vaccine.
    Nathanson N; Mathieson BJ
    J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hunt for the AIDS vaccine.
    Essex M
    AIDS Asia; 1995; 2(3):10-3. PubMed ID: 12319586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons for AIDS vaccine development from non-AIDS vaccines.
    Clements-Mann ML
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.